Articles 

- Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and                 prevention of Asthma

     Gunerka P, Gala K, Banach M, Dominowski J, Hucz-Kalitowska J, Mulewski K, Hajnal A, Mikus EG, Smuga D, Zagozda M, Dubiel K,               Pieczykolan J, Zygmunt BM, Wieczorek M.

- Potential L-Type Voltage-Operated Calcium Channel Blocking Effect of Drotaverine on Functional Models.

      Patai Z, Guttman A, Mikus EG.

-  Assessment of the Airway Smooth Muscle Relaxant Effect of Drotaverine.

     Patai Z, Guttman A, Mikus EG.

-   Cell-type-specific determination of reactive oxygen species by flow cytometry.

     Hajnal A, Bogdandi N, Marokházi J, Guba D, Mikus EG.

-   Evaluation of SSR 161421, a novel orally active adenodine A₃ receptor antagonist on pharmacology models
     Endre G. Mikus, Judit Szeredi, Kinga Boer, Geza Timari, Michel Finet, Peter Aranyi, Anne-Marie Glazin

-   Interaction of SSR 161421, a novel specific adenosine A3 receptor antagonist with adenosine A3 receptor agonists both in vitro and in vivo
     Endre G. Mikus, Kinga Boer, Geza Timari, Katalin Urban-Szabo, Zoltan Kapui, Judit Szeredi, Katalin Gerber, Tibor Szabo, Sandor Batori, Michel Finet, Peter Aranyi, Anne-Marie Glazin

Editorial activities

-   Adenosine A₃ receptor

-   GPR84 receptor

Presentations

-   A Magyar Andrológiai Tudományos Társaság VIII. Kongresszusa
    13-15. November 2014